Mizuho Securities Upgrades Quest Diagnostics (DGX) to Buy; Set to Outperform Again in 2017
Tweet Send to a Friend
Mizuho Securities upgraded Quest Diagnostics (NYSE: DGX) from Neutral to Buy with a price target of $103.00 (from $88.00), saying ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
